Genocea Biosciences, Inc. (GNCAQ)

Genocea Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Feb 18, 2025	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Market Capitalization	0	67	125	54	25	33
Market Cap Growth	-49.38%	-46.67%	130.85%	117.88%	-24.47%	-71.87%
Enterprise Value	53	37	62	28	6	27
Last Close Price	0.00	1.16	2.42	2.07	2.29	9.28
PS Ratio	0.00	40.61	91.95	-	-	-
PB Ratio	5.93	2.46	13.91	2.16	3.39	-5.44
P/TBV Ratio	5.93	2.46	13.91	2.22	3.74	-
EV/Sales Ratio	27.97	22.29	45.69	-	-	-
Debt / Equity Ratio	1.25	0.63	2.66	0.80	2.02	-2.37
Asset Turnover	0.03	0.02	0.02	-	-	-
Quick Ratio	1.12	1.99	3.19	6.39	2.46	0.78
Current Ratio	1.35	2.24	3.29	6.62	2.52	0.83
Return on Equity (ROE)	-525.78%	-184.13%	-256.96%	-240.60%	-4328.56%	-287.20%
Return on Assets (ROA)	-57.59%	-43.05%	-38.87%	-58.21%	-101.63%	-75.30%
Return on Capital (ROIC)	-143.44%	-86.22%	-75.48%	-72.61%	-162.40%	-92.98%
Earnings Yield	-63035593.22%	-49.82%	-34.98%	-71.96%	-111.94%	-172.40%
FCF Yield	-86993220.34%	-73.02%	-35.40%	-71.81%	-166.94%	-148.29%
Buyback Yield / Dilution	-29.43%	-47.31%	-125.50%	-100.02%	-188.67%	-1.07%
Total Shareholder Return	-29.43%	-47.31%	-125.50%	-100.02%	-188.67%	-1.07%

Source: S&P Capital IQ. Standard template. Financial Sources.